Home
Innate Immune Enhancers Minimising the Impact of Viral Respiratory Infections
ENA Respiratory is a clinical-stage pharmaceutical company developing innate immune enhancers for the prevention of complications associated with respiratory viral infections in at-risk populations.
ENA Respiratory Announces Extension of U.S. Department of Defense Funding for Novel Prophylactic Antiviral
ENA Respiratory Progresses Phase Ib Study of its Dry Powder Formulation of Intranasal Innate Immunomodulator INNA-051